Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Perez

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
European Radiology|November 5, 2025
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancerSungmin Woo, Luca Russo, Samuel J Withey, et al.
Ophthalmology|March 24, 2019
Genomic Landscape of Sporadic Retinitis Pigmentosa: Findings from 877 Spanish CasesInmaculada Martin-Merida, Almudena Avila-Fernandez, Marta Del Pozo-Valero, et al.
Scientific Reports|January 26, 2016
Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis PigmentosaRaquel Perez-Carro, Marta Corton, Iker Sánchez-Navarro, et al.
Cancer Research Communications|December 21, 2023
Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 ExpressionMarta Ligero, Garazi Serna, Omar S M El Nahhas, et al.
European Radiology|June 9, 2022
Quantification and reduction of cross-vendor variation in multicenter DWI MR imaging: results of the Cancer Core Europe imaging task forceOliver Lukas Sedlaczek, Jens Kleesiek, Ferdia A Gallagher, et al.
Clinical Genitourinary Cancer|June 3, 2017
Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden HospitalDiletta Bianchini, David Lorente, Pasquale Rescigno, et al.
BJC Reports|November 8, 2024
Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trialMarta Ligero, Jorge Hernando, Eric Delgado, et al.
European Urology|December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetateRoberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
Nutrients|August 14, 2025
Hepatic Olfr734 Deficiency Worsens Hepatic Glucose Metabolism and Induces MASLD in MiceEva Prida, Diego Muñoz-Moreno, Eva Novoa, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
European Radiology|November 5, 2025
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancerSungmin Woo, Luca Russo, Samuel J Withey, et al.
Ophthalmology|March 24, 2019
Genomic Landscape of Sporadic Retinitis Pigmentosa: Findings from 877 Spanish CasesInmaculada Martin-Merida, Almudena Avila-Fernandez, Marta Del Pozo-Valero, et al.
Scientific Reports|January 26, 2016
Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis PigmentosaRaquel Perez-Carro, Marta Corton, Iker Sánchez-Navarro, et al.
Cancer Research Communications|December 21, 2023
Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 ExpressionMarta Ligero, Garazi Serna, Omar S M El Nahhas, et al.
European Radiology|June 9, 2022
Quantification and reduction of cross-vendor variation in multicenter DWI MR imaging: results of the Cancer Core Europe imaging task forceOliver Lukas Sedlaczek, Jens Kleesiek, Ferdia A Gallagher, et al.
Clinical Genitourinary Cancer|June 3, 2017
Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden HospitalDiletta Bianchini, David Lorente, Pasquale Rescigno, et al.
BJC Reports|November 8, 2024
Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trialMarta Ligero, Jorge Hernando, Eric Delgado, et al.
European Urology|December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetateRoberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
Nutrients|August 14, 2025
Hepatic Olfr734 Deficiency Worsens Hepatic Glucose Metabolism and Induces MASLD in MiceEva Prida, Diego Muñoz-Moreno, Eva Novoa, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Pageof 17